tiprankstipranks
Trending News
More News >
Clinigence Holdings Inc (NUTX)
:NUTX
US Market

Clinigence Holdings (NUTX) Ratios

Compare
371 Followers

Clinigence Holdings Ratios

NUTX's free cash flow for Q3 2025 was $0.58. For the 2025 fiscal year, NUTX's free cash flow was decreased by $ and operating cash flow was $0.48. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.20 1.56 1.79 4.09 4.31
Quick Ratio
3.18 1.50 1.72 4.01 4.25
Cash Ratio
0.90 0.38 0.62 0.96 0.81
Solvency Ratio
0.26 -0.09 -1.35 0.69 0.66
Operating Cash Flow Ratio
1.21 0.02 0.92 4.60 2.58
Short-Term Operating Cash Flow Coverage
6.91 0.09 3.34 16.95 4.36
Net Current Asset Value
$ 66.17M$ -228.29M$ -213.45M$ -49.05M$ -25.68M
Leverage Ratios
Debt-to-Assets Ratio
0.34 0.69 0.62 0.45 0.49
Debt-to-Equity Ratio
1.03 4.49 2.79 1.56 1.75
Debt-to-Capital Ratio
0.51 0.82 0.74 0.61 0.64
Long-Term Debt-to-Capital Ratio
0.07 0.30 0.19 0.41 0.49
Financial Leverage Ratio
3.04 6.48 4.50 3.44 3.60
Debt Service Coverage Ratio
5.47 -0.31 -14.72 11.11 -2.23
Interest Coverage Ratio
15.71 -1.95 -0.41 27.48 23.68
Debt to Market Cap
0.06 0.34 <0.01 <0.01 <0.01
Interest Debt Per Share
52.23 66.26 6.62 4.60 3.65
Net Debt to EBITDA
0.45 -17.40 -0.59 0.78 -24.35
Profitability Margins
Gross Profit Margin
55.01%14.04%6.13%54.08%99.33%
EBIT Margin
34.79%-12.99%-185.67%52.99%56.02%
EBITDA Margin
36.89%-5.89%-179.65%55.33%-1.87%
Operating Profit Margin
35.72%-12.83%-2.34%51.36%55.71%
Pretax Profit Margin
32.51%-19.58%-191.36%51.12%53.24%
Net Profit Margin
11.63%-18.49%-197.33%39.99%38.76%
Continuous Operations Profit Margin
26.21%-17.53%-197.33%50.83%53.24%
Net Income Per EBT
35.76%94.42%103.12%78.23%72.80%
EBT Per EBIT
91.03%152.61%8167.95%99.55%95.55%
Return on Assets (ROA)
11.83%-11.50%-100.23%33.60%34.34%
Return on Equity (ROE)
45.74%-74.51%-451.42%115.65%123.50%
Return on Capital Employed (ROCE)
44.99%-9.35%-1.36%47.70%54.97%
Return on Invested Capital (ROIC)
34.81%-7.90%-1.33%45.74%33.32%
Return on Tangible Assets
12.28%-12.69%-109.96%33.75%34.47%
Earnings Yield
10.58%-38.47%-3.59%0.05%0.04%
Efficiency Ratios
Receivables Turnover
2.53 3.94 3.76 2.89 2.53
Payables Turnover
8.91 8.42 8.60 8.62 0.21
Inventory Turnover
139.78 62.78 58.26 54.10 1.05
Fixed Asset Turnover
2.92 0.92 0.74 1.39 1.60
Asset Turnover
1.02 0.62 0.51 0.84 0.89
Working Capital Turnover Ratio
2.86 6.55 2.75 3.01 7.04
Cash Conversion Cycle
105.75 54.99 60.89 90.77 -1.24K
Days of Sales Outstanding
144.11 92.52 97.06 126.34 144.36
Days of Inventory Outstanding
2.61 5.81 6.27 6.75 346.17
Days of Payables Outstanding
40.98 43.35 42.43 42.32 1.73K
Operating Cycle
146.73 98.34 103.33 133.09 490.53
Cash Flow Ratios
Operating Cash Flow Per Share
33.54 0.29 1.20 4.32 1.89
Free Cash Flow Per Share
33.43 -1.87 0.85 3.40 0.47
CapEx Per Share
0.23 2.15 0.35 0.92 1.43
Free Cash Flow to Operating Cash Flow
1.00 -6.56 0.71 0.79 0.25
Dividend Paid and CapEx Coverage Ratio
9.75 0.09 0.77 0.96 0.68
Capital Expenditure Coverage Ratio
148.65 0.13 3.46 4.70 1.33
Operating Cash Flow Coverage Ratio
0.69 <0.01 0.19 0.97 0.54
Operating Cash Flow to Sales Ratio
0.23 <0.01 0.23 0.52 0.30
Free Cash Flow Yield
23.38%-6.92%0.30%0.06%<0.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
9.46 -2.60 -27.84 1.82K 2.43K
Price-to-Sales (P/S) Ratio
0.98 0.48 54.93 727.17 941.75
Price-to-Book (P/B) Ratio
3.40 1.94 125.66 2.10K 3.00K
Price-to-Free Cash Flow (P/FCF) Ratio
4.28 -14.44 334.85 1.77K 12.83K
Price-to-Operating Cash Flow Ratio
4.80 94.73 238.03 1.39K 3.17K
Price-to-Earnings Growth (PEG) Ratio
0.09 0.03 0.07 71.66 4.26
Price-to-Fair Value
3.40 1.94 125.66 2.10K 3.00K
Enterprise Value Multiple
3.09 -25.57 -31.17 1.31K -50.34K
Enterprise Value
1.12B 372.78M 12.28B 241.22B 257.62B
EV to EBITDA
3.09 -25.57 -31.17 1.31K -50.34K
EV to Sales
1.14 1.51 55.99 727.60 942.20
EV to Free Cash Flow
5.00 -45.24 341.32 1.77K 12.83K
EV to Operating Cash Flow
4.98 296.69 242.63 1.39K 3.17K
Tangible Book Value Per Share
60.07 9.42 1.94 4.72 3.41
Shareholders’ Equity Per Share
47.33 13.94 2.27 2.85 2.00
Tax and Other Ratios
Effective Tax Rate
0.19 0.10 -0.03 <0.01 0.35
Revenue Per Share
146.42 56.18 5.19 8.25 6.37
Net Income Per Share
17.02 -10.39 -10.24 3.30 2.47
Tax Burden
0.36 0.94 1.03 0.78 0.73
Interest Burden
0.93 1.51 1.03 0.96 0.95
Research & Development to Revenue
0.00 0.00 0.00 <0.01 <0.01
SG&A to Revenue
0.06 0.13 0.08 0.02 0.42
Stock-Based Compensation to Revenue
0.14 0.01 <0.01 0.00 <0.01
Income Quality
0.85 -0.03 -0.12 1.03 0.56
Currency in USD